"ImmediCenter bridges the gap between primary care doctor's offices and hospital emergency rooms. National studies indicate that more than half of the people who visit emergency rooms are not in need of the level of care provided at hospitals. Urgent care facilities effectively handle patient cases in instances when individuals do not have a primary care provider."

During the past decade, Immedicenter conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Immedicenter" are "Subjective Tinnitus" (2 trials), "Acute Upper Respiratory Track Infection" (1 trials) and "Lower Back Pain" (1 trials). Many other conditions were trialed in "Immedicenter" in a lesser frequency.

Most popular intervention types in "Immedicenter" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Neramexane mesylate" (2 trials), "Carisoprodol SR 500 mg" (1 trials), "Carisoprodol SR 700 mg" (1 trials) and "Guaifenesin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Immedicenter" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Immedicenter". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Immedicenter, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Immedicenter, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".